Seer, Inc. (SEER)
Automate Your Wheel Strategy on SEER
With Tiblio's Option Bot, you can configure your own wheel strategy including SEER - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol SEER
- Rev/Share 0.2553
- Book/Share 5.235
- PB 0.3763
- Debt/Equity 0.0817
- CurrentRatio 19.3443
- ROIC -0.2849
- MktCap 115927059.0
- FreeCF/Share -0.851
- PFCF -2.2931
- PE -1.363
- Debt/Assets 0.0732
- DivYield 0
- ROE -0.2548
- Rating C+
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 1
- P/B Score 5
- D/E Score 3
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| No ratings available. | |||||||
News
What Makes Seer, Inc. (SEER) a Strong Momentum Stock: Buy Now?
Published: June 10, 2025 by: Zacks Investment Research
Sentiment: Positive
Does Seer, Inc. (SEER) have what it takes to be a top stock pick for momentum investors? Let's find out.
Read More
After Plunging -16.81% in 4 Weeks, Here's Why the Trend Might Reverse for Seer (SEER)
Published: March 24, 2025 by: Zacks Investment Research
Sentiment: Negative
Seer (SEER) is technically in oversold territory now, so the heavy selling pressure might have exhausted. This along with strong agreement among Wall Street analysts in raising earnings estimates could lead to a trend reversal for the stock.
Read More
Down -10.53% in 4 Weeks, Here's Why Seer (SEER) Looks Ripe for a Turnaround
Published: March 06, 2025 by: Zacks Investment Research
Sentiment: Positive
The heavy selling pressure might have exhausted for Seer (SEER) as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising earnings estimates higher indicates that the stock is ripe for a trend reversal.
Read More
Seer, Inc. (SEER) Q4 2024 Earnings Call Transcript
Published: February 27, 2025 by: Seeking Alpha
Sentiment: Neutral
Seer, Inc. (NASDAQ:SEER ) Q4 2024 Earnings Conference Call February 27, 2025 4:30 PM ET Company Participants Carrie Mendivil - Investor Relations Omid Farokhzad - Chief Executive Officer and Chair of the Board David Horn - Chief Financial Officer and President Conference Call Participants Marta Zaremba - JPMorgan Jason Lai - Morgan Stanley Operator Good day and thank you for standing by. Welcome to the Seer Fourth Quarter and Full-Year 2024 Earnings Conference Call.
Read More
Seer, Inc. (SEER) Reports Q4 Loss, Tops Revenue Estimates
Published: February 27, 2025 by: Zacks Investment Research
Sentiment: Negative
Seer, Inc. (SEER) came out with a quarterly loss of $0.34 per share versus the Zacks Consensus Estimate of a loss of $0.40. This compares to loss of $0.28 per share a year ago.
Read More
Seer to Feature Proteomic Advancements in Cancer and RNA Therapy Research among other Findings at US HUPO 2025
Published: February 20, 2025 by: GlobeNewsWire
Sentiment: Neutral
Seminar from Dr. Jinjun Shi from Brigham and Women's Hospital and Harvard Medical School to highlight study of proteomic perturbations resulting from a novel approach to cancer therapy revealed using Seer's Proteograph™ Product Suite Seminar from Dr. Jinjun Shi from Brigham and Women's Hospital and Harvard Medical School to highlight study of proteomic perturbations resulting from a novel approach to cancer therapy revealed using Seer's Proteograph™ Product Suite
Read More
About Seer, Inc. (SEER)
- IPO Date 2020-12-04
- Website https://seer.bio
- Industry Biotechnology
- CEO Dr. Omid C. Farokhzad M.D., Ph.D.
- Employees 134